258 related articles for article (PubMed ID: 19487252)
1. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine.
Bélanger AS; Caron P; Harvey M; Zimmerman PA; Mehlotra RK; Guillemette C
Drug Metab Dispos; 2009 Sep; 37(9):1793-6. PubMed ID: 19487252
[TBL] [Abstract][Full Text] [Related]
2. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A
Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
[TBL] [Abstract][Full Text] [Related]
5. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831
[TBL] [Abstract][Full Text] [Related]
7. Identification of human UGT isoforms responsible for glucuronidation of efavirenz and its three hydroxy metabolites.
Bae SK; Jeong YJ; Lee C; Liu KH
Xenobiotica; 2011 Jun; 41(6):437-44. PubMed ID: 21319958
[TBL] [Abstract][Full Text] [Related]
8. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
Chen M; LeDuc B; Kerr S; Howe D; Williams DA
Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
[TBL] [Abstract][Full Text] [Related]
9. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
[TBL] [Abstract][Full Text] [Related]
10. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO
Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204
[TBL] [Abstract][Full Text] [Related]
11. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
12. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
13. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.
Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM
Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989
[TBL] [Abstract][Full Text] [Related]
15. Effect of efavirenz on UDP-glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 activities in human liver microsomes.
Ji HY; Lee H; Lim SR; Kim JH; Lee HS
Molecules; 2012 Jan; 17(1):851-60. PubMed ID: 22252501
[TBL] [Abstract][Full Text] [Related]
16. In vitro glucuronidation of fenofibric acid by human UDP-glucuronosyltransferases and liver microsomes.
Tojcic J; Benoit-Biancamano MO; Court MH; Straka RJ; Caron P; Guillemette C
Drug Metab Dispos; 2009 Nov; 37(11):2236-43. PubMed ID: 19661212
[TBL] [Abstract][Full Text] [Related]
17. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
18. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
19. Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate.
Ji JZ; Huang BB; Gu TT; Tai T; Zhou H; Jia YM; Mi QY; Zhang MR; Xie HG
Biopharm Drug Dispos; 2018 Feb; 39(2):88-98. PubMed ID: 29240983
[TBL] [Abstract][Full Text] [Related]
20. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]